Pharmafile Logo
Pharmafocus logo
Advanced Search

Pay-for-delay deals up 60% in US

May 6, 2011
Sales and Marketing FTC, generics

Deals to delay generic drugs from coming onto the US market have more than doubled. The Federal Trade Commission’s staff …

News

‘Weak’ evidence leads to NICE no for three leukaemia drugs

May 6, 2011
Sales and Marketing Glivec, NICE, Sprycel, Tasigna

NICE has not recommended three major drugs for the rare blood cancer chronic myeloid leukaemia. In draft guidance on treating …

News
Novartis' Afinitor (everolimus)

Novartis’ Afinitor wins landmark US approval

May 6, 2011
Sales and Marketing Afinitor, Novartis

Novartis’ Afinitor has been approved in the US for the treatment of progressive neuroendocrine tumours of pancreatic origin (PNET) in …

News

Digital Pharma: Sanofi Pasteur MSD takes Quora approach to vaccines

May 6, 2011
Medical Communications Digital Pharma blog, Sanofi Pasteur, vaccines

Sanofi Pasteur MSD is aiming to tackle myths and misconceptions about vaccines with a Quora-like online health information campaign in …

News
nitrogen_europe_jon_clark

Jon Clark gains European leadership role at Nitrogen

May 6, 2011
Medical Communications appointment, medical communications

Huntsworth Health has promoted Jon Clark to European managing director of its brand communications agency Nitrogen. He will report to …

Appointment

Ogilvy picks Carsten Edwards to lead new market access business

May 6, 2011
Medical Communications, Sales and Marketing Ogilvy, Ogilvy Healthworld Market Access, medical communications

Ogilvy Healthworld has appointed Carsten Edwards to head its new market access business. Edwards will be managing partner of market …

News

Thomas Lingelbach appointed chief executive of Intercell

May 5, 2011
Research and Development appointment, research and development

Vienna-based biotech Intercell has appointed Thomas Lingelbach as chief executive with effect from 10 May. He has more than twenty …

Appointment

INC Research to acquire Kendle

May 5, 2011
Research and Development INC Research, Kendle, cros

Two contract research organisations INC Research and Kendle International are to merge to create a new major player in the …

News

Sanofi signs malaria research alliance

May 5, 2011
Research and Development Medicines for Malaria Venture, Sanofi-Aventis, malaria

Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …

News

Prostate cancer drug Zytiga gains US approval

May 5, 2011
Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer

Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …

News
Sanofi-Aventis' Plavix (clopidogrel)

Plavix sales plummet in England

May 5, 2011
Sales and Marketing BMS, Plavix, Sanofi-Aventis, clopidogrel

GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …

News

Debiopharm and Yale University to develop autoimmune treatment

May 5, 2011
Research and Development Debiopharm, Yale University

Debiopharm is teaming up with researchers at Yale University to develop Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory …

News
Pfizer

Pfizer sales flat as Lipitor revenues decline

May 4, 2011
Sales and Marketing Pfizer

Pfizer’s sales decreased slightly in the first quarter after rising revenues in specialty care and emerging markets failed to offset …

News

Hospitals face greater than expected savings target

May 4, 2011
Monitor, NHS reforms, foundation trusts

Hospitals are being asked to nearly double their savings target as a result of the increasingly tough economic environment they …

News
Roche's Avastin (bevacizumab)

Avastin as effective as Lucentis in eye disease

May 4, 2011
Research and Development Lucentis, avastin, off label, wet AMD

Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …

News

Astellas adds senior executives to global development team

May 4, 2011
Research and Development appointment, research and development

Astellas Pharma has made four new senior appointments to its US-based global development team. Former Eli Lilly vice president of …

Appointment

Service Insight: Due diligence in emerging markets for clinical development

May 4, 2011
Research and Development Service Insight, Talking Point, research and development

SERVICE INSIGHT Currently, the pharma industry is experiencing an unprecedented wave of blockbuster drug patent expiries. There is a lack …

Feature

Contract research news in brief

May 4, 2011
Research and Development contract research, cros, research and development

This week’s CRO news roundup includes Omnicare CR and LAB Research changing hands, Q1 financials for ICON and PPD and …

News
ABPI Code of Practice

UK pharma reassured over dealings with health bodies

May 3, 2011
Medical Communications, Sales and Marketing 2011 ABPI Code, Code of Practice, medical communications, risk-sharing

UK pharma has been reassured over the use of risk-sharing schemes with health bodies. The latest revisions to the ABPI …

News

US approval for Boehringer’s diabetes drug Tradjenta

May 3, 2011
Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Tradjenta, the once-daily oral type II diabetes treatment developed by Boehringer Ingelheim, has been approved by US regulators. The FDA …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026